ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

A Personal Spin on Migraine-Associated Vertigo Treatments: With few formal guidelines, otolaryngologists use trial and error

by Bryn Nelson • June 1, 2011

  • Tweet
  • Email
Print-Friendly Version

Patients with uncontrolled migraine-associated vertigo who had failed other drug treatments found relief with the drug, Dr. Foster said. “But this is really early, so we don’t know yet what the difficulties that we’re going to encounter with the drug are.”

You Might Also Like

  • What Are the Diagnostic Criteria for Migraine-Associated Vertigo?
  • Vertigo in the Elderly: What Does It Mean?
  • Migraine-Associated Dizziness Is Elusive to Diagnose
  • FDA Advisory on Triptans and SSRI/SNRIs Will Not Affect Migraine Treatment, Say Experts
Explore This Issue
June 2011

Specialists agreed that other potent drugs like topiramate (Topamax), used to treat seizures in epilepsy patients, should likewise be reserved as a third-line option if other regimens fail. Dr. Goebel cautioned that he’s encountered cognitive problems among some patients on the drug. “You get some word-finding problems, not being able to exactly come up with the word you want to use,” he said.

Similarly, beta blockers like propranolol (Inderal) may be effective but can have a significant downside. “The problem with Inderal as a beta blocker is that if you give it to a younger person, not only does it lower their blood pressure, but it lowers their exercise tolerance,” Dr. Goebel said. Dr. Foster also uses propranolol sparingly, but noted that it can be a good choice for migraine patients with tremor or high blood pressure.

A similarly intense medication like the anti-epileptic and altitude sickness drug acetazolamide (Diamox) may likewise help in more severe cases, Dr. Foster said, such as vertigo with damaging hearing loss. Diamox, Inderal and the occasionally prescribed anti-seizure medication lamotrigine (Lamictal) may not stop headaches, though, potentially requiring such patients to take more than one drug.

Experts have pointed to some limited success with the depression and generalized anxiety disorder drug escitalopram (Lexapro), although the medication is prescribed primarily by neurologists. Another small randomized clinical trial pointed to zolmitriptan (Zomig) as a somewhat beneficial abortive treatment, a rarity among triptans. And an observational study found marginal improvement with the blood pressure medication metoprolol (Lopressor, Toprol) (J Neurol. 2009 256(5):711-716).

The take-away lesson, otolaryngologists say, is that a suite of symptoms still in search of clear categorization may nevertheless respond to a carefully chosen, individually tailored treatment regimen that stops the spinning world of vertigo patients.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Everyday Ethics, Head and Neck, Medical Education, Otology/Neurotology, Special Reports Tagged With: migraine, neurotology, otolaryngologist, treatment, vertigoIssue: June 2011

You Might Also Like:

  • What Are the Diagnostic Criteria for Migraine-Associated Vertigo?
  • Vertigo in the Elderly: What Does It Mean?
  • Migraine-Associated Dizziness Is Elusive to Diagnose
  • FDA Advisory on Triptans and SSRI/SNRIs Will Not Affect Migraine Treatment, Say Experts

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.